Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | FAAH | O00519 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | F7 | P08709 | 2/20 | 0.54 |
| ▸ | F3 | P13726 | 2/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.54 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30408097 | 0.92 | FAAH (0.67) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL27763201 | 0.90 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL8635209 | 0.87 | PRKCA (0.63) | ALDH1A1MAPTFAAHHPGDCNR1 | |
| SCHEMBL5680978 | 0.87 | PRKCA (0.63) | ALDH1A1MAPTFAAHHPGDCNR1 | |
| SCHEMBL29454642 | 0.86 | ALDH1A1 (0.62) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL9754748 | 0.86 | ALDH1A1 (0.56) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL1986196 | 0.85 | ALDH1A1 (0.76) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL27893799 | 0.84 | ALDH1A1 (0.68) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL27995339 | 0.84 | FAAH (0.64) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL3654529 | 0.83 | ALDH1A1 (0.66) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | claimed |
| CN-111471529-B | Glycerol esterification method for high acid value oil | 河南恒天久大实业有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-113068693-B | Composite veterinary disinfectant containing glutaraldehyde and ammonium decamethylammonium bromide | 江苏康巴特生物工程有限公司 | 2022-05-13 | — | — | CN | claimed |
| EP-3988091-B1 | SOLID SOLUTION COMPOSITIONS FOR NSAIDS | INFIRST HEALTHCARE LTD (GB) | 2025-10-01 | — | — | EP | disclosed |
| EP-3795141-B1 | SOLID SOLUTION COMPOSITIONS | INFIRST HEALTHCARE LTD (GB) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025129333-A1 | LIPID NANOPARTICLES HAVING NON-POLAR LIPIDS FOR NUCLEIC ACID DELIVERY TO THE LIVER | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-26 | — | — | WO | disclosed |
| US-20250195433-A1 | Compositions Having Improved Bioavailability of Therapeutics and Uses Thereof | TRx Biosciences Limited (GB) | 2025-06-19 | — | — | US | disclosed |
| WO-2025093572-A1 | SOLID DISPERSION COMPOSITIONS AND USES THEREOF | TRx Biosciences Limited (GB) | 2025-05-08 | — | — | WO | disclosed |
| CN-119677509-A | Fibrate composition for the treatment of inflammation and neuroinflammation | 特瑞克思生物科学有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-12226484-B2 | Compositions having improved bioavailability of therapeutics | TRx Biosciences Limited (GB) | 2025-02-18 | — | — | US | disclosed |
| EP-4493178-A1 | FIBRATE COMPOSITIONS FOR TREATING INFLAMMATION AND NEUROINFLAMMATION | TRX Biosciences Limited (GB) | 2025-01-22 | — | — | EP | disclosed |
| CN-115397431-A | ECLITASERTIB for the treatment of disorders involving systemic excessive inflammatory response | 建新公司 | 2022-11-25 | — | — | CN | disclosed |
| WO-2022207580-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS | TRx Biosciences Limited (GB) | 2022-10-06 | — | — | WO | disclosed |
| US-20220305125-A1 | Compositions Having Improved Bioavailability of Therapeutics | TRx Biosciences Limited (GB) | 2022-09-29 | — | — | US | disclosed |
| CN-113068693-B | Composite veterinary disinfectant containing glutaraldehyde and ammonium decamethylammonium bromide | 江苏康巴特生物工程有限公司 | 2022-05-13 | — | — | CN | disclosed |
| EP-3988091-A1 | SOLID SOLUTION COMPOSITIONS FOR NSAIDS | InFirst Healthcare Limited (GB) | 2022-04-27 | — | — | EP | disclosed |
| US-20220118091-A1 | Solid Solution Compositions and Use in Severe Pain | INFIRST HEALTHCARE LIMITED (GB) | 2022-04-21 | — | — | US | disclosed |
| US-20220096637-A1 | Solid Solution Compositions and Use in Cardiovascular Disease | INFIRST HEALTHCARE LIMITED (GB) | 2022-03-31 | — | — | US | disclosed |
| CN-107427468-B | Site-specific administration of BTK inhibitors | 普林斯匹亚生物制药公司 | 2022-02-25 | — | — | CN | disclosed |
| US-20220040102-A1 | Solid Solution Compositions and Use in Chronic Inflammation | INFIRST HEALTHCARE LIMITED (GB) | 2022-02-10 | — | — | US | disclosed |